Skip to main content

Olanzapine (International)

In the US, Olanzapine (olanzapine systemic) is a member of the drug class atypical antipsychotics and is used to treat Agitated State, Agitation, Anorexia, Anorexia Nervosa, Asperger Syndrome, Bipolar Disorder, Body Dysmorphic Disorder, Borderline Personality Disorder, Depression, Depressive Psychosis, Insomnia, Major Depressive Disorder, Nausea/Vomiting, Nausea/Vomiting - Chemotherapy Induced, Obsessive Compulsive Disorder, Paranoid Disorder, Schizoaffective Disorder, Schizophrenia and Tourette's Syndrome.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N05AH03

CAS registry number (Chemical Abstracts Service)

0132539-06-1

Chemical Formula

C17-H20-N4-S

Molecular Weight

312

Therapeutic Categories

Neuroleptic agent

Benzodiazepine derivative

Serotonin receptor antagonist

Chemical Name

10H-tieno[2,3-b][1,5]benzodiazepine, 2-metyl-4-(4-metyl-1-piperazinyl)-

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs